{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:11:35Z","timestamp":1784931095458,"version":"3.55.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T00:00:00Z","timestamp":1233705600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Intervention Psych"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:<\/jats:bold> This naturalistic study aims to compare discontinuation rates for low\u2010dose first\u2010generation versus second\u2010generation antipsychotics in first\u2010episode psychotic patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The prescription of antipsychotic medication in 301 consecutively admitted patients with first\u2010episode psychosis from four catchment areas is described. For the first year of inclusion a first\u2010generation antipsychotic in low dose was recommended as the first medication. From the second year a second\u2010generation antipsychotic was recommended as first choice. Switching was allowed when any drug was judged to be ineffective or to have serious side\u2010effects. Switching during the first 2\u2003years after inclusion is described.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Switching from a low\u2010dose first\u2010generation antipsychotic was more frequent than from a second\u2010generation antipsychotic (90.7 vs. 58.4%). Lack of therapeutic effect and side\u2010effects were the more frequently recorded reasons for changing in the first\u2010generation group. Akathisia, parkinsonism, dyskinesias, dystonia and dysphoria were more often reported in patients on first\u2010generation drugs. Weight gain and sedation were more often reported in patients on second\u2010generation drugs.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The findings suggest a better adherence to and tolerability for second\u2010generation antipsychotics than for low\u2010dose first\u2010generation antipsychotics in first\u2010episode psychosis.<\/jats:p>","DOI":"10.1111\/j.1751-7893.2008.00103.x","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T00:11:13Z","timestamp":1233706273000},"page":"58-65","source":"Crossref","is-referenced-by-count":20,"title":["Stability of medication in early psychosis: a comparison between second\u2010generation and low\u2010dose first\u2010generation antipsychotics"],"prefix":"10.1111","volume":"3","author":[{"given":"Stein","family":"Opjordsmoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Haahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan O.","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor K.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn R.","family":"Rund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Vaglum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"McGlashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,4]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"75","volume-title":"WPA Series Evidence and Experience in Psychiatry","author":"Fleischhacker WW","year":"1999"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson DG","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13306-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.8.1396"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.13"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.4.692"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.103"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.54.5.719"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.7.1301"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.6.782"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.8.1396"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.5.947"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3180582426"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1079"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.019307"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.2.143"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.466"},{"key":"e_1_2_6_20_2","volume-title":"Structural Clinical Interview for DSM\u2010IV Axis I Disorders \u2013 Patient Edition (SCID I\/P, Version 2.0)","author":"First MB","year":"1995"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2006.03.008"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2003.02600.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03366.x"},{"issue":"19","key":"e_1_2_6_25_2","first-page":"5","article-title":"Use patters for antipsychotic medications in medicaid patients with schizophrenia","volume":"60","author":"McCombs JS","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.7.1050"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000245563.06660.0f"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-6-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000245562.99036.92"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0704"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2005.09.009"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.1.1.2"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.3.241"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.10.1888"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.164.3.375"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2004.00478.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2004.00486.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00309-7"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318166c4f7"},{"key":"e_1_2_6_40_2","unstructured":"BirkenaesAB BirkelandKI FriisS OpjordsmoenS AndreassenOA.Hormonal markers of metabolic dysregulation in patients with severe mental disorders following olanzapine treatment under real life conditions.J Clin Psychopharmacol(in press)."}],"container-title":["Early Intervention in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7893.2008.00103.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7893.2008.00103.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:52:49Z","timestamp":1697050369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7893.2008.00103.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1751-7893.2008.00103.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7893.2008.00103.x","archive":["Portico"],"relation":{},"ISSN":["1751-7885","1751-7893"],"issn-type":[{"value":"1751-7885","type":"print"},{"value":"1751-7893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}